- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 473/32 - Atome d'azote
Détention brevets de la classe C07D 473/32
Brevets de cette classe: 253
Historique des publications depuis 10 ans
|
20
|
19
|
17
|
9
|
28
|
14
|
21
|
11
|
13
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Signal Pharmaceuticals, LLC | 173 |
17 |
| Boehringer Ingelheim International GmbH | 4490 |
9 |
| Celgene Corporation | 1405 |
8 |
| Chengdu Baiyu Pharmaceutical Co., Ltd. | 68 |
6 |
| Kangbaida (Sichuan) Biotechnology Co., Ltd. | 51 |
6 |
| Board of Regents, The University of Texas System | 6225 |
5 |
| Takeda Pharmaceutical Company Limited | 2704 |
5 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 239 |
5 |
| S*BIO Pte Ltd. | 19 |
5 |
| AstraZeneca AB | 2841 |
4 |
| Purdue Research Foundation | 4000 |
4 |
| Cancer Research Technology Limited | 519 |
4 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 387 |
4 |
| Neupharma, Inc. | 73 |
4 |
| Research Triangle Institute | 419 |
4 |
| Shanghai Hansoh Biomedical Co., Ltd. | 378 |
4 |
| F. Hoffmann-La Roche AG | 7777 |
3 |
| The Regents of the University of California | 20989 |
3 |
| Wyeth LLC | 599 |
3 |
| Ildong Pharmaceutical Co., Ltd. | 93 |
3 |
| Autres propriétaires | 147 |